RxDoctor Payments Data

Loretta Dickson, MD

Family Medicine · Forest City, NCNPI 1376513523

Payments from drug & device makers

$1,039in general payments, 2019–2025

Across 67 payments — averaging $15.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$187
  • GSK$173
  • AstraZeneca$165
  • Biohaven Pharmaceutical Holding Company Ltd.$72
  • Novartis$70
  • Lilly USA, LLC$54
  • plus $318 from 12 others

What the payments were for

  • Food & beverage$1,039100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,039 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$100,472
Medicare patients
255
Services billed
1,846

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide113$139,202
EliquisApixaban176$135,883
JardianceEmpagliflozin126$106,833
XareltoRivaroxaban46$47,738
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$45,800
MounjaroTirzepatide32$37,538
Breo ElliptaFluticasone/Vilanterol55$37,362
Tresiba Flextouch U-100Insulin Degludec33$34,263
Tresiba Flextouch U-200Insulin Degludec27$32,758
JanuviaSitagliptin Phosphate31$29,162
FarxigaDapagliflozin Propanediol17$22,761
TrintellixVortioxetine Hydrobromide39$22,208
LinzessLinaclotide19$14,086
Emgality PenGalcanezumab-Gnlm17$11,293
ShingrixVaricella-Zoster Ge/As01b/Pf53$10,947

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$12$145,004206 claims
Novo NordiskOzempic$187$139,202113 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix, Arexvy$173$100,718190 claims
Johnson & JohnsonXarelto$45$47,73846 claims
Lilly USA, LLCMounjaro$54$37,53832 claims
MerckJanuvia$32$29,16231 claims
AstraZenecaFarxiga, Brilinta$165$29,14829 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$44$22,20839 claims
AbbVieLinzess$40$14,08619 claims
Sanofi-aventis U.S. LLCLantus$14$3,33734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Forest City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →